Obsidio Overview

  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 5

Obsidio General Information


Developer of universal immobilization biomaterial products designed to restore health and extending life by stopping undesirable flow in vessels anywhere in the body. The company's products offer gel embolic material as well as provide minimally-invasive occlusive agents using a shear-thinning biomaterial (STB) technology, enabling physicians to stop undesired blood flow through vessels in vascular embolotherapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 1502 Main Street
  • Columbia, SC 29201
  • United States
+1 (267) 000-0000

Obsidio Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Obsidio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 06-Aug-2020 $4M 000 Completed Pre-Clinical Trials
4. Grant 06-Aug-2020 00000 Completed Pre-Clinical Trials
3. Seed Round 21-Aug-2019 Completed Pre-Clinical Trials
2. Accelerator/Incubator 26-Jul-2019 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Mar-2017 Completed Pre-Clinical Trials
To view Obsidio’s complete valuation and funding history, request access »

Obsidio Executive Team (4)

Name Title Board Seat Contact Info
Ehsan Jabbarzadeh Ph.D Co-Founder, Board Member & Chief Executive Officer
Ali Khademhosseini Ph.D Co-Founder & Scientific Board Member
Rahmi Oklu Ph.D Co-Founder, Board Member & Chief Medical Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Obsidio Board Members (4)

Name Representing Role Since
Ali Khademhosseini Ph.D Obsidio Co-Founder & Scientific Board Member 000 0000
Ehsan Jabbarzadeh Ph.D Obsidio Co-Founder, Board Member & Chief Executive Officer 000 0000
Jeffrey Gold Obsidio Board Member 000 0000
Rahmi Oklu Ph.D Obsidio Co-Founder, Board Member & Chief Medical Officer 000 0000
To view Obsidio’s complete board members history, request access »

Obsidio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Obsidio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
Good Growth Capital Venture Capital Minority 000 0000 000000 0
IAG Capital Partners Venture Capital Minority 000 0000 000000 0
TMC Innovation Accelerator/Incubator Minority 000 0000 000000 0
MassCONNECT Accelerator/Incubator Minority 000 0000 000000 0
To view Obsidio’s complete investors history, request access »